Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: effect of conditioning regimen on outcome.

Burt RK, Han X, Gozdziak P, Yaung K, Morgan A, Clendenan AM, Henry J, Calvario MA, Datta SK, Helenowski I, Schroeder J.

Bone Marrow Transplant. 2018 Jun;53(6):692-700. doi: 10.1038/s41409-018-0173-x. Epub 2018 May 31.

PMID:
29855561
2.

Systemic sclerosis: Autologous HSCT is efficacious, but can we make it safer?

Burt RK, Farge D.

Nat Rev Rheumatol. 2018 Apr;14(4):189-191. doi: 10.1038/nrrheum.2018.34. Epub 2018 Mar 8. No abstract available.

PMID:
29515186
3.

Blogs cannot separate wheat from chaff.

Burt RK, Snowden JA, Burman J, Oliveira MC, Sharrack B.

Science. 2017 Nov 3;358(6363):602. doi: 10.1126/science.aar2575. No abstract available.

PMID:
29097540
4.

Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn's disease.

Ruiz MA, Kaiser RL Jr, de Quadros LG, Piron-Ruiz L, Peña-Arciniegas T, Faria MAG, Siqueira RC, Pirozzi FF, Kaiser FSL, Burt RK.

BMC Res Notes. 2017 Oct 6;10(1):495. doi: 10.1186/s13104-017-2824-1.

5.

Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners.

Farge D, Burt RK, Oliveira MC, Mousseaux E, Rovira M, Marjanovic Z, de Vries-Bouwstra J, Del Papa N, Saccardi R, Shah SJ, Lee DC, Denton C, Alexander T, Kiely DG, Snowden JA.

Bone Marrow Transplant. 2017 Nov;52(11):1495-1503. doi: 10.1038/bmt.2017.56. Epub 2017 May 22. Review.

6.

Stem-cell transplantation for Crohn's disease: same authors, different conclusions?

Burt RK, Kaiser RL Jr, Ruiz MA.

Lancet Gastroenterol Hepatol. 2017 Jun;2(6):386-387. doi: 10.1016/S2468-1253(17)30076-6. Epub 2017 Apr 6. No abstract available.

PMID:
28497747
7.

Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes.

Malmegrim KC, de Azevedo JT, Arruda LC, Abreu JR, Couri CE, de Oliveira GL, Palma PV, Scortegagna GT, Stracieri AB, Moraes DA, Dias JB, Pieroni F, Cunha R, Guilherme L, Santos NM, Foss MC, Covas DT, Burt RK, Simões BP, Voltarelli JC, Roep BO, Oliveira MC.

Front Immunol. 2017 Feb 22;8:167. doi: 10.3389/fimmu.2017.00167. eCollection 2017.

8.

Stem Cell Transplantation for Refractory Crohn Disease.

Burt RK, Ruiz MA, Kaiser RL Jr.

JAMA. 2016 Jun 21;315(23):2620. doi: 10.1001/jama.2016.4030. No abstract available.

PMID:
27327808
9.

Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.

Burt RK, Balabanov R, Han X, Sharrack B, Morgan A, Quigley K, Yaung K, Helenowski IB, Jovanovic B, Spahovic D, Arnautovic I, Lee DC, Benefield BC, Futterer S, Oliveira MC, Burman J.

JAMA. 2015 Jan 20;313(3):275-84. doi: 10.1001/jama.2014.17986.

PMID:
25602998
10.

Cardiac assessment before stem cell transplantation for systemic sclerosis.

Burt RK, Oliveira MC, Shah SJ.

JAMA. 2014 Nov 5;312(17):1803. doi: 10.1001/jama.2014.12566. No abstract available.

PMID:
25369497
11.

Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis.

de Paula A Sousa A, Malmegrim KC, Panepucci RA, Brum DS, Barreira AA, Carlos Dos Santos A, Araújo AG, Covas DT, Oliveira MC, Moraes DA, Pieroni F, Barros GM, Simões BP, Nicholas R, Burt RK, Voltarelli JC, Muraro PA.

Clin Sci (Lond). 2015 Jan;128(2):111-20. doi: 10.1042/CS20140095.

PMID:
25116724
12.

Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity.

Zhang L, Bertucci AM, Ramsey-Goldman R, Harsha-Strong ER, Burt RK, Datta SK.

Clin Immunol. 2013 Dec;149(3):365-78. doi: 10.1016/j.clim.2013.08.008. Epub 2013 Aug 23.

13.

Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.

Abrahamsson SV, Angelini DF, Dubinsky AN, Morel E, Oh U, Jones JL, Carassiti D, Reynolds R, Salvetti M, Calabresi PA, Coles AJ, Battistini L, Martin R, Burt RK, Muraro PA.

Brain. 2013 Sep;136(Pt 9):2888-903. doi: 10.1093/brain/awt182. Epub 2013 Jul 17.

14.

Autologous HSCT for systemic sclerosis - Authors' reply.

Burt RK, Shah SJ, Schroeder J, Oliveira MC, Moraes DA, Simoes B, Marjanovic Z, Farge D.

Lancet. 2013 Jun 15;381(9883):2080-1. doi: 10.1016/S0140-6736(13)61241-6. No abstract available.

PMID:
23769228
15.

Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis.

Burt RK, Oliveira MC, Shah SJ, Moraes DA, Simoes B, Gheorghiade M, Schroeder J, Ruderman E, Farge D, Chai ZJ, Marjanovic Z, Jain S, Morgan A, Milanetti F, Han X, Jovanovic B, Helenowski IB, Voltarelli J.

Lancet. 2013 Mar 30;381(9872):1116-24. doi: 10.1016/S0140-6736(12)62114-X. Epub 2013 Jan 28.

PMID:
23363664
16.

Remission of Crohn's disease after cord blood transplantation for leukocyte adhesion deficiency type 1.

Jain S, Gozdziak P, Morgan A, Burt RK.

Bone Marrow Transplant. 2013 Jul;48(7):1006-7. doi: 10.1038/bmt.2012.274. Epub 2013 Jan 21. No abstract available.

PMID:
23334270
17.

Mitotically inactivated embryonic stem cells can be used as an in vivo feeder layer to nurse damaged myocardium after acute myocardial infarction: a preclinical study.

Burt RK, Chen YH, Verda L, Lucena C, Navale S, Johnson J, Han X, Lomasney J, Baker JM, Ngai KL, Kino A, Carr J, Kajstura J, Anversa P.

Circ Res. 2012 Oct 26;111(10):1286-96. doi: 10.1161/CIRCRESAHA.111.262584. Epub 2012 Aug 22.

18.

Autologous hematopoietic stem cell transplantation for multiple sclerosis--if confused or hesitant, remember: 'treat with standard immune suppressive drugs and if no inflammation, no response'.

Burt RK, Balabanov R, Voltarelli J, Barreira A, Burman J.

Mult Scler. 2012 Jun;18(6):772-5. doi: 10.1177/1352458512442993. No abstract available.

PMID:
22619224
19.

Hematopoietic stem cell transplantation for systemic sclerosis: if you are confused, remember: "it is a matter of the heart".

Burt RK, Shah SJ, Gheorghiade M, Ruderman E, Schroeder J.

J Rheumatol. 2012 Feb;39(2):206-9. doi: 10.3899/jrheum.111302. No abstract available.

PMID:
22298260
20.

Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus.

Illei GG, Cervera R, Burt RK, Doria A, Hiepe F, Jayne D, Pavletic S, Martin T, Marmont A, Saccardi R, Voskuyl AE, Farge D.

Ann Rheum Dis. 2011 Dec;70(12):2071-4. doi: 10.1136/ard.2010.148049. Epub 2011 Aug 26.

21.

Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.

Burt RK, Milanetti F.

Curr Opin Rheumatol. 2011 Nov;23(6):519-29. doi: 10.1097/BOR.0b013e32834aa45f. Review.

PMID:
21857226
22.

Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.

Burt RK, Shah SJ, Dill K, Grant T, Gheorghiade M, Schroeder J, Craig R, Hirano I, Marshall K, Ruderman E, Jovanovic B, Milanetti F, Jain S, Boyce K, Morgan A, Carr J, Barr W.

Lancet. 2011 Aug 6;378(9790):498-506. doi: 10.1016/S0140-6736(11)60982-3. Epub 2011 Jul 21.

PMID:
21777972
23.

Autologous hematopoietic stem cell transplantation for systemic sclerosis.

Milanetti F, Bucha J, Testori A, Burt RK.

Curr Stem Cell Res Ther. 2011 Mar;6(1):16-28. Review.

PMID:
20955159
24.

Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up.

Burt RK, Craig RM, Milanetti F, Quigley K, Gozdziak P, Bucha J, Testori A, Halverson A, Verda L, de Villiers WJ, Jovanovic B, Oyama Y.

Blood. 2010 Dec 23;116(26):6123-32. doi: 10.1182/blood-2010-06-292391. Epub 2010 Sep 13.

25.

Risks of immune system treatments.

Burt RK, Abinun M, Farge-Bancel D, Fassas A, Hiepe F, Havrdová E, Ikehara S, Loh Y, Marmont du Haut Champ A, Voltarelli JC, Snowden J, Slavin S.

Science. 2010 May 14;328(5980):825-6. doi: 10.1126/science.328.5980.825-e. No abstract available.

PMID:
20466903
26.

Autologous hematopoietic stem cell transplantation for childhood autoimmune disease.

Milanetti F, Abinun M, Voltarelli JC, Burt RK.

Pediatr Clin North Am. 2010 Feb;57(1):239-71. doi: 10.1016/j.pcl.2009.12.003. Review.

PMID:
20307720
27.

The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation.

Levitsky J, Miller J, Leventhal J, Huang X, Flaa C, Wang E, Tambur A, Burt RK, Gallon L, Mathew JM.

Transplantation. 2009 Dec 15;88(11):1303-11. doi: 10.1097/TP.0b013e3181bbee98.

28.

Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus.

Zhang L, Bertucci AM, Ramsey-Goldman R, Burt RK, Datta SK.

J Immunol. 2009 Nov 15;183(10):6346-58. doi: 10.4049/jimmunol.0901773. Epub 2009 Oct 19.

29.

Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG.

Hamerschlak N, Rodrigues M, Moraes DA, Oliveira MC, Stracieri AB, Pieroni F, Barros GM, Madeira MI, Simões BP, Barreira AA, Brum DG, Ribeiro AA, Kutner JM, Tylberi CP, Porto PP, Santana CL, Neto JZ, Barros JC, Paes AT, Burt RK, Oliveira EA, Mastropietro AP, Santos AC, Voltarelli JC.

Bone Marrow Transplant. 2010 Feb;45(2):239-48. doi: 10.1038/bmt.2009.127. Epub 2009 Jul 6.

PMID:
19584827
30.

T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft.

Dubinsky AN, Burt RK, Martin R, Muraro PA.

Bone Marrow Transplant. 2010 Feb;45(2):325-31. doi: 10.1038/bmt.2009.139. Epub 2009 Jun 22.

PMID:
19543329
31.

A case of autoimmune-related retinopathy and optic neuropathy syndrome treated by autologous nonmyeloablative hematopoietic stem cell transplantation.

Oyama Y, Burt RK, Thirkill C, Hanna E, Merrill K, Keltner J.

J Neuroophthalmol. 2009 Mar;29(1):43-9. doi: 10.1097/WNO.0b013e318199becf.

PMID:
19458576
32.

Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia.

Burt RK, Testori A, Oyama Y, Rodriguez HE, Yaung K, Villa M, Bucha JM, Milanetti F, Sheehan J, Rajamannan N, Pearce WH.

Bone Marrow Transplant. 2010 Jan;45(1):111-6. doi: 10.1038/bmt.2009.102. Epub 2009 May 18.

33.

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simões BP, Martinez EZ, Foss MC, Burt RK, Voltarelli JC.

JAMA. 2009 Apr 15;301(15):1573-9. doi: 10.1001/jama.2009.470.

PMID:
19366777
34.

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.

Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Oyama Y, Russell EJ, Stern J, Muraro P, Rose J, Testori A, Bucha J, Jovanovic B, Milanetti F, Storek J, Voltarelli JC, Burns WH.

Lancet Neurol. 2009 Mar;8(3):244-53. doi: 10.1016/S1474-4422(09)70017-1. Epub 2009 Jan 29. Erratum in: Lancet Neurol. 2009 Apr;8(4):309. Stefosky, Dusan [corrected to Stefoski, Dusan].

35.

Autologous hematopoietic stem cell transplantation for type 1 diabetes.

Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simões BP, Foss MC, Squiers E, Burt RK.

Ann N Y Acad Sci. 2008 Dec;1150:220-9. doi: 10.1196/annals.1447.048. Review.

PMID:
19120300
36.

Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases.

Marmont AM, Burt RK.

Autoimmunity. 2008 Dec;41(8):639-47. doi: 10.1080/08916930802198345. Review.

PMID:
18958753
37.

Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation.

Wen Y, Ouyang J, Yang R, Chen J, Liu Y, Zhou X, Burt RK.

Biochem Biophys Res Commun. 2008 Sep 19;374(2):282-7. doi: 10.1016/j.bbrc.2008.07.016. Epub 2008 Jul 14.

PMID:
18625200
38.

Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation.

Mandelbrot DA, Santos PW, Burt RK, Oyama Y, Block GA, Ahya SN, Rosa RM, Traynor AE.

Nephrol Dial Transplant. 2008 Aug;23(8):2679-84. doi: 10.1093/ndt/gfn036. Epub 2008 Mar 7.

PMID:
18326564
39.

Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases.

Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R, Wen Y, Rapp JA, Kessler J.

JAMA. 2008 Feb 27;299(8):925-36. doi: 10.1001/jama.299.8.925. Review.

PMID:
18314435
40.

Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?

Burt RK, Testori A, Craig R, Cohen B, Suffit R, Barr W.

J Autoimmun. 2008 May;30(3):116-20. doi: 10.1016/j.jaut.2007.12.010. Epub 2008 Feb 1. Review. Erratum in: J Autoimmun. 2008 Aug;31(1): 90.. Testor, Alessandro [corrected to Testori, Alessandro]..

PMID:
18242956
41.

Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.

Verda L, Kim DA, Ikehara S, Statkute L, Bronesky D, Petrenko Y, Oyama Y, He X, Link C, Vahanian NN, Burt RK.

Stem Cells. 2008 Feb;26(2):381-6. Epub 2007 Nov 1.

42.

Nonmyeloablative autologous hematopoietic stem celltransplantation for refractory CIDP.

Oyama Y, Sufit R, Loh Y, Statkute L, Yaung K, Quigley K, Gonda E, Spahovic D, Bronesky D, Burt RK.

Neurology. 2007 Oct 30;69(18):1802-3. No abstract available.

PMID:
17967996
43.

Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis.

Statkute L, Oyama Y, Barr WG, Sufit R, Ho S, Verda L, Loh Y, Yaung K, Quigley K, Burt RK.

Ann Rheum Dis. 2008 Jul;67(7):991-7. Epub 2007 Oct 18.

PMID:
17947303
44.

Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.

Oyama Y, Barr WG, Statkute L, Corbridge T, Gonda EA, Jovanovic B, Testori A, Burt RK.

Bone Marrow Transplant. 2007 Sep;40(6):549-55. Epub 2007 Jul 23.

PMID:
17646844
45.

Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission.

Loh Y, Oyama Y, Statkute L, Traynor A, Satkus J, Quigley K, Yaung K, Barr W, Bucha J, Gheorghiade M, Burt RK.

Bone Marrow Transplant. 2007 Jul;40(1):47-53. Epub 2007 May 7.

PMID:
17483845
46.

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KC, Foss-Freitas MC, Simões BP, Foss MC, Squiers E, Burt RK.

JAMA. 2007 Apr 11;297(14):1568-76.

PMID:
17426276
47.

Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?

Loh Y, Oyama Y, Statkute L, Verda L, Quigley K, Yaung K, Barr W, Jovanovic B, Burt RK.

Bone Marrow Transplant. 2007 Apr;39(7):435-7. Epub 2007 Feb 19. No abstract available.

PMID:
17310133
48.

Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation.

Statkute L, Verda L, Oyama Y, Traynor A, Villa M, Shook T, Clifton R, Jovanovic B, Satkus J, Loh Y, Quigley K, Yaung K, Gonda E, Krosnjar N, Spahovic D, Burt RK.

Bone Marrow Transplant. 2007 Mar;39(6):317-29. Epub 2007 Feb 5.

PMID:
17277794
49.

Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.

Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, Fassas A, Snowden J, Schuening F, Myint H, Patel DD, Collier D, Heslop H, Krance R, Statkute L, Verda L, Traynor A, Kozak T, Hintzen RQ, Rose JW, Voltarelli J, Loh Y, Territo M, Cohen BA, Craig RM, Varga J, Barr WG.

Arthritis Rheum. 2006 Dec;54(12):3750-60. Review. No abstract available.

50.

Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used.

Loh Y, Oyama Y, Statkute L, Quigley K, Yaung K, Gonda E, Barr W, Jovanovic B, Craig R, Stefoski D, Cohen B, Burt RK.

Blood. 2007 Mar 15;109(6):2643-548. Epub 2006 Nov 21.

Supplemental Content

Support Center